The efficacy of the inhalation of an aerosolized Group A streptococcal preparation in the treatment of lung cancer

Chinese Journal of Cancer Research

Volumn 24, Issue 4, 2012, Pages 346-352

  Liu, Jun ^a,b   Liu, Xiang ^c,d   Cui, Fei ^a,b   Chen, Guoqin ^a,b   Guan, Yubao ^a   He, Jianxing ^a,b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d THE SECOND AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Group A streptococcal (GAS); Lewis lung carcinoma cell; lung cancer

Indexed keywords

PICIBANIL; SODIUM CHLORIDE;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DEATH; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEASIBILITY STUDY; INHALATION; LEWIS CARCINOMA; MOUSE; NONHUMAN; OVERALL SURVIVAL; QUALITY OF LIFE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STREPTOCOCCUS GROUP A; WEIGHT GAIN;

EID: 84875413770     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-012-0274-9     Document Type: Article

References (20)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Voon PJ, Chul Cho B, Yeo WL, et al. The role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of advanced stage non-small cell lung cancer. J Thorac Dis 2010;2:144-153.
3. Pirker R, Filipits M. Cetuximab in non-small cell lung cancer. Transl Lung Cancer Res 2012;1:54-60.
4. Li YQ, Shi AH, Li FH, et al. Phase I study to determine MTD of docetaxel and cisplatin with concurrent radiation therapy for stage III non-small cell lung cancer. Chin J Cancer Res 2011;23:129-133.
5. Yang P, Xu XY, Liu XJ, et al. The value of delayed 18F FDG-PET imaging in diagnosis of solitary pulmonary nodules: A preliminary study on 28 patients. Quant Imaging Med Surg 2011;1:31-34.
6. Hennon MW, Demmy TL. Video-assisted thoracoscopic surgery (VATS) for locally advanced lung cancer. Ann Cardiothorac Surg 2012;1:37-42.
7. Okamoto H, Shoin S, Koshimura S, et al. Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn J Microbiol 1967;11:323-326.
8. Hojo H, Hashimoto Y. Cytotoxic cells induced in tumor-bearing rats by a streptococcus preparation (OK-432). Gann 1981;72:692-699.
9. Luh KT, Yang PC, Kuo SH, et al. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer 1992;69:674-679.
10. Liu X, Liu J, Guan Y, et al. Establishment of an orthotopic lung cancer model in nude mice and its evaluation by spiral CT. J Thorac Dis 2012;4:141-145.
11. Winter H, van den Engel NK, Rusan M, et al. Active-specific immunotherapy for non-small cell lung cancer. J Thorac Dis 2011;3:105-114.
12. Park SH, Zhu Y, Ozden O, et al. SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis. Transl Cancer Res 2012;1:15-21.
13. Murala S, Alli V, Kreisel D, et al. Current status of immunotherapy for the treatment of lung cancer. J Thorac Dis 2010;2:237-244.
14. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003;56:588-599.
15. Ichite N, Chougule M, Patel AR, et al. Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer. Mol Cancer Ther 2010;9:3003-3014.
16. Wang Z, Chen HT, Roa W, et al. Farnesol for aerosol inhalation: nebulization and activity against human lung cancer cells. J Pharm Pharm Sci 2003;6:95-100.
17. Zhou C, Manegold C. Chemotherapy of lung cancer: A global perspective of the role of ifosfamide. Transl Lung Cancer Res 2012;1:61-71.
18. Wittgen BP, Kunst PW, van der Born K, et al. Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung. Clin Cancer Res 2007;13:2414-2421.
19. Oshimi K, Kano S, Takaku F, et al. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. J Natl Cancer Inst 1980;65:1265-1269.
20. Misaki T, Watanabe Y, Iida Y, et al. Recruitment of T lymphocytes and induction of tumor necrosis factor in thyroid cancer by a local immunotherapy. Cancer Immunol Immunother 1992;35:92-96.